Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Demoralization in patients with obsessive-compulsive disorder: results from an exploratory cross-sectional report.

Annals of general psychiatry·2026
Same author

The final appointment: risk factors and prevention of femicide.

Rivista di psichiatria·2026
Same author

Is There a Relationship Between Movement and Sleep Disturbances in Essential Tremor?

Brain sciences·2026
Same author

Acceptability of cannabidiol as a treatment for people at clinical high risk for psychosis.

Frontiers in psychiatry·2026
Same author

Psychopathological Concomitants and Motivations Related to Misuse of Non-Steroidal Anti-Inflammatory Drugs and Paracetamol.

Human psychopharmacology·2026
Same author

Increased salience network connectivity in college students who engage in binge drinking: A resting state EEG study.

Drug and alcohol dependence·2026

Related Experiment Video

Updated: Feb 24, 2026

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
05:52

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis

Published on: November 21, 2013

15.6K

Clozapine-related extrapyramidal side effects: a case report.

Mariana Gallo1, Chiara Squarcione1, Francesco Saverio Bersani1

  • 1Department of Neurology and Psychiatry, Sapienza University of Rome, Italy.

Rivista Di Psichiatria
|August 29, 2017
PubMed
Summary

Long-term, low-dose clozapine treatment can still cause extrapyramidal side effects (EPS). This highlights that even the safest antipsychotics carry neurological risks.

More Related Videos

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
07:35

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans

Published on: February 4, 2014

12.0K
Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization
12:00

Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization

Published on: November 19, 2014

13.3K

Related Experiment Videos

Last Updated: Feb 24, 2026

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
05:52

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis

Published on: November 21, 2013

15.6K
Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
07:35

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans

Published on: February 4, 2014

12.0K
Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization
12:00

Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization

Published on: November 19, 2014

13.3K

Area of Science:

  • Neuroscience
  • Psychopharmacology
  • Clinical Neurology

Background:

  • Clozapine is an atypical antipsychotic widely used for treatment-resistant schizophrenia.
  • It is generally associated with a lower risk of extrapyramidal side effects (EPS) compared to older antipsychotics.
  • Clozapine is sometimes used to manage EPS caused by other medications.

Observation:

  • A case report details the emergence of EPS after 32 months of continuous, low-dose clozapine monotherapy.
  • The patient experienced specific neurological symptoms indicative of EPS.

Findings:

  • Long-term exposure to clozapine, even at low doses, can precipitate extrapyramidal side effects.
  • This challenges the perception of clozapine as entirely free from neurological risks.

Implications:

  • Clinicians should remain vigilant for EPS in patients on long-term clozapine, regardless of dosage.
  • The risk-benefit profile of clozapine requires ongoing assessment, considering potential neurological sequelae.
  • Further research may be needed to understand the mechanisms underlying late-onset EPS with clozapine.